Ocular symptoms and signs with preserved and preservative-free glaucoma medications

被引:306
|
作者
Jaenen, N.
Baudouin, C.
Pouliquen, P.
Manni, G.
Figueiredo, A.
Zeyen, T.
机构
[1] UZ Sint Rafael, Louvain, Belgium
[2] CNO XVXX, Paris, France
[3] Lab Thea, Clermont Ferrand, France
[4] Policlin Tor Vergata, Rome, Italy
[5] Hosp Santa Maria, Lisbon, Portugal
关键词
glaucoma; preserved and preservative free eyedrops; side effects;
D O I
10.1177/112067210701700311
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To compare the prevalence of side effects between eyedrops with or without preservatives, in terms of subjective symptoms and objective signs in patients with open-angle glaucoma. METHODS. In a multicenter cross-sectional epidemiologic survey in four European countries, ophthalmologists in private practice enrolled 9658 nonconsecutive patients using preservative (P) or preserva tive-free (PF) beta-blocking eyedrops between June 1997 and December 2003. Subjective symptoms, conjunctival and palpebral signs, and superficial punctate keratitis were explored before and after a change in therapy. For statistical analysis, a chi(2) test was used to calculate the differences in the prevalence of symptoms and signs with or without preservatives. RESULTS. A total of 74% of the patients used P, 12% PF, 10% a P-PF combination, and in 4% the type of medication was unknown. Each recorded symptom and all the palpebral, conjunctival, and corneal signs were significantly more frequent (p<0.0001) in the P-group than in the PF-group, such as pain or discomfort during instillation (48 vs 19%), foreign body sensation (42 vs 15%), stinging or burning (48 vs 20%), and dry eye sensation (35 vs 16%). A total of 68% of the patients had a second visit performed, of whom 63% (6083) had been evaluated on treatment difference. A significant decrease (p<0.0001) of all ocular symptoms and signs was observed in patients in whom the preserved eyedrops were diminished in number or altered into preservative free drops. CONCLUSIONS. Compared to preserved eyedrops, preservative free eyedrops are significantly less associated with ocular symptoms and signs of irritation.
引用
收藏
页码:341 / 349
页数:9
相关论文
共 50 条
  • [1] Ocular symptoms and signs with preserved and preservative-free glaucoma medications (vol 17, pg 341, 2007)
    Jaenen, N.
    Baudouin, C.
    Pouliquen, R.
    Manni, G.
    Figueiredo, A.
    Zeyen, T.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2007, 17 (04) : 688 - 688
  • [2] Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
    Pisella, PJ
    Pouliquen, P
    Baudouin, C
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (04) : 418 - 423
  • [3] BAK to the Future? Preserved and Preservative-Free Topical Glaucoma Medications
    Saeedi, Osamah
    Chen, Victoria
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2022, 48 (04): : 139 - 140
  • [4] Factors Affecting the Ocular Surface in Glaucoma Patients Using Preservative-Free Ocular Hypotensive Medications
    Garcia y Otero Sanchez, Sara Aurora
    Paczka, Jose A.
    Giorgi Sandoval, Luz A.
    Paczka-Giorgi, Luz America
    Ponce Horta, Ana
    Tornero-Jimenez, Andrea
    Ibanez Sandoval, Miguel Angel
    Orozco Garcia, Andrea
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [5] Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
    Paul Harasymowycz
    Cindy Hutnik
    Jean-François Rouland
    Francisco J. Muñoz Negrete
    Mario A. Economou
    Philippe Denis
    Christophe Baudouin
    Advances in Therapy, 2021, 38 : 3019 - 3031
  • [6] A REVIEW OF PRESERVED AND PRESERVATIVE-FREE PROSTAGLANDIN ANALOGUES FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION
    Hommer, A.
    DRUGS OF TODAY, 2010, 46 (06) : 409 - 416
  • [7] Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
    Harasymowycz, Paul
    Hutnik, Cindy
    Rouland, Jean-Francois
    Negrete, Francisco J. Munoz
    Economou, Mario A.
    Denis, Philippe
    Baudouin, Christophe
    ADVANCES IN THERAPY, 2021, 38 (06) : 3019 - 3031
  • [8] Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension
    Carl Erb
    Ines Lanzl
    Seid-Fatima Seidova
    Friedemann Kimmich
    Advances in Therapy, 2011, 28
  • [9] In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system
    Blondin, C
    Hamard, P
    Cholley, B
    Haeffner-Cavaillon, N
    Baudouin, C
    CURRENT EYE RESEARCH, 2003, 27 (04) : 253 - 259
  • [10] Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
    Lanzl, Ines
    Hamacher, Thomas
    Rosbach, Klaus
    Ramez, Mohammed Osman
    Rothe, Robert
    Ruzickova, Eva
    Karhanova, Marta
    Kimmich, Friedemann
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 901 - 909